Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Cancer
National Cancer Institute (NCI)P1CC (43)
Panitumumab
Castration-Resistant Prostate Carcinoma
Biosplice Therapeutics, Inc.P1CC (43)
Panitumumab
Pancreatic Ductal Adenocarcinoma
Astellas Pharma IncP1CC (43)
Pantoprazole
Colorectal Cancer
toqa saad mohammed mohammedP1CC (43)
Papaverine
Non-Small Cell Lung Carcinoma
Ohio State University Comprehensive Cancer CenterP1CC (43)
Papaverine
Rectum Adenocarcinoma
City of Hope Medical CenterP1CC (43)
Papaverine
Lung Cancer
Ohio State University Comprehensive Cancer CenterP1CC (43)
Papaverine
Rectal Cancer
City of Hope Medical CenterP1CC (43)
Parsaclisib
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Mayo ClinicP1CC (43)
Parsaclisib
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
Parsaclisib
T-Cell Non-Hodgkin Lymphoma
Walter HanelP1CC (43)
Pas-004 Capsules
Neurofibromatosis Type 1
Pasithea Therapeutics Corp.P1CC (43)
Pas-004 Tablets
Neurofibromatosis Type 1
Pasithea Therapeutics Corp.P1CC (43)
Pavurutamab
Plasma Cell Myeloma
AmgenP1CC (43)
Paxalisib
Neoplastic Meningitis
Memorial Sloan Kettering Cancer CenterP1CC (43)
Pazopanib
Cancer Or Benign Tumor
National Cancer Institute (NCI)P1CC (43)
pb101
Cancer
Panolos BioscienceP1CC (43)
pb101
Gastric Cancer
Panolos BioscienceP1CC (43)
pb101
Hepatocellular Carcinoma
Panolos BioscienceP1CC (43)
pb101
Colorectal Cancer
Panolos BioscienceP1CC (43)
pb101
Neoplasm
Panolos BioscienceP1CC (43)
Pbf-1129
Non-Small Cell Lung Carcinoma
Dwight OwenP1CC (43)
PBR111
Traumatic Brain Injury
University of North Carolina, Chapel HillP1CC (43)
Pebezertinib
Adenocarcinoma
Blueprint Medicines CorporationP1CC (43)
Pebezertinib
Chemotherapy-Induced Toxicity
Blueprint Medicines CorporationP1CC (43)
Showing 3726 to 3750 of 9,920 assets
PreviousPage 150 of 397Next